代谢组学与网络药理学揭示艾灸透皮成分及其治疗类风湿关节炎机制
研究采用GC-MS鉴定艾灸皮下组织透皮成分(TMOCs)共54种,结合网络药理学预测其中16种具抗RA活性,TNF-α为核心靶点。体外实验显示柠檬醛抑制RA-FLS增殖与炎症,α-松油醇和冰片抑制侵袭。AIA大鼠模型证实柠檬醛局部给药改善关节炎症状。
要点
- 艾灸透皮成分中柠檬醛、α-松油醇和冰片稳定结合TNF-α。
- 柠檬醛经抑制MAPK通路抑制RA-FLS增殖与炎症。
- α-松油醇和冰片调节MMP-1/MMP-2 mRNA抑制RA-FLS侵袭。
核心结论
- 柠檬醛、α-松油醇和冰片是靶向TNF-α减轻RA的三种核心透皮艾灸成分。
- 柠檬醛通过抑制MAPK通路抑制滑膜增殖和炎症,α-松油醇/冰片调节MMP介导的侵袭。
研究设计与样本
- 采用GC-MS提取皮下组织中TMOCs的相对浓度并纳入网络药理学分析。
- 用GC-MS和标准品定量与主要靶点相关的TMOCs皮下浓度。
- 通过分子对接和分子动力学模拟检测TMOCs-靶点相互作用。
- 分离原代RA-FLS,用EdU增殖实验、免疫荧光、RTCA、ELISA、qPCR和Western blotting评估核心TMOCs的生物学效应。
- 在佐剂诱导性关节炎(AIA)大鼠模型中确认体内疗效。
主要发现
- 共鉴定54种TMOCs,其中16种被预测具有抗RA活性。
- 网络药理学表明关键TMOCs可能通过调节炎症和细胞增殖减轻RA,TNF-α为中心靶点。
- 柠檬醛、α-松油醇和冰片是稳定与TNF-α相互作用的TMOCs。
- 体外实验中,柠檬醛抑制RA-FLS增殖,减少TNF-α和COX-2分泌,下调RA-FLS中ERK1/2、p38和c-JUN蛋白表达水平。
- α-松油醇和冰片抑制RA-FLS侵袭并调节MMP-1和MMP-2的mRNA表达水平。
临床怎么用
- 艾灸治疗RA的透皮成分中,柠檬醛、α-松油醇和冰片可作为潜在活性标志物。
- 柠檬醛局部给药可能通过抑制MAPK通路和TNF-α发挥抗RA作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/PURPOSE: Moxibustion, a traditional therapy employing the combustion of Artemisia argyi, exerts notable clinical benefits in rheumatoid arthritis (RA). However, the identity of the transdermal moxibustion compounds (TMOCs) and their molecular mechanisms of action remain poorly understood. This study sought to define the core TMOCs and delineate their therapeutic mechanisms in RA. STUDY DESIGN/METHOD: GC-MS was used to extract the relative concentrations of TMOCs in the subcutaneous tissue, which were incorporated into the network pharmacology to identify the center targets of primary TMOCs for RA. Meanwhile, the subcutaneous concentrations of TMOCs associated with the identified primary targets were quantified using GC-MS and standards. TMOCs-target interactions were examined via molecular docking and molecular dynamics simulation. Primary RA-derived fibroblast-like synoviocytes (RA-FLS) were isolated to evaluate biological effects of the core TMOCs using EdU proliferation assays, immunofluorescence, real-time cell analysis (RTCA), ELISA, qPCR, and Western blotting. In vivo efficacy was confirmed in the adjuvant-induced arthritis (AIA) rat model. RESULTS: A total of 54 TMOCs were identified, among which 16 were predicted to possess anti-RA activity. Network pharmacology indicated that essential TMOCs may mitigate RA by regulating inflammation and cellular proliferation, where TNF-α serves as a centered target. In addition, Citral, α-Terpineol and Borneol are the TMOCs stably interacting with TNF-α. In vitro, Citral inhibits the proliferation of RA-FLS, reduces the secretion of TNF-α and COX-2, and downregulates the protein expression levels of ERK1/2, p38 and c-JUN in RA-FLS. Meanwhile, α-Terpineol and Borneol inhibit RA-FLS invasion and modulate the mRNA expression levels of MMP-1 and MMP-2. In vivo, local administration of Citral to the plantar subcutaneous tissue ameliorated arthritic symptoms in AIA rats. CONCLUSION: This study identified three promising TMOCs, Citral, α-Terpineol and Borneol, which target TNF-α to attenuate RA. Citral suppresses synovial proliferation and inflammation via MAPK pathway inhibition, while α-terpineol/borneol modulate MMP-mediated invasion.
引用
- Lai J, Lan T, Wang T, et al. Metabolomics and network pharmacology revealing the transdermal moxibustion compounds and their therapeutic mechanisms for rheumatoid arthritis. Phytomedicine. 2025. PMID: 41172921. doi:10.1016/j.phymed.2025.157479
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。